Xifaxan 550 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FX29R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,889
Award facts
- Contract value 100% obligated
- $4,888.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Xifaxan 550 mg tablets (60-count packages) under a firm fixed price contract valued at $4,888.67. This competitively awarded delivery order, with no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, leveraging its comprehensive IDC to supply an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The DLA Pharmaceutical Prime Vendor Global Program Generation V initiative, of which this delivery order is a component, is structured to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with flexible and scalable pharmaceutical procurement capabilities. This award demonstrates AmerisourceBergen's continued role as a key vendor for federal medical supply requirements within the Defense Logistics Agency's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DB25FX29R?
SPE2DB25FX29R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FX29R worth?
The government has obligated $4,889 on SPE2DB25FX29R.
Is contract SPE2DB25FX29R an order under another contract?
Yes. SPE2DB25FX29R is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FX29R competed?
The extent of competition for SPE2DB25FX29R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award